Home NDC 50881-006 ZYNYZ
Product NDC 50881-006
11-digit product format 508810006
Labeler code 50881
Product ID 50881-006_4b5a0ce6-7f12-44aa-9b45-05188a37da9d
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name retifanlimab-dlwr
Dosage form INJECTION
Route INTRAVENOUS
Labeler Incyte Corporation
Application BLA761334
Marketing category BLA
Marketing start 2023-03-22
Substance RETIFANLIMAB
Active strength 25 mg/mL
Pharmacologic classes Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base ZYNYZ
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength RETIFANLIMAB 25 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2Y3T5IF01Z Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2632985 Internal RxNorm lookup 2632991 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50881-006-03 ZYNYZ 1 in 1 CARTON INJECTION 1 16 50881-006-03 ZYNYZ 20 mL in 1 VIAL, SINGLE-USE INJECTION 20 16
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50881-006 ZYNYZ (RETIFANLIMAB-DLWR) INJECTION [INCYTE CORPORATION] 7 Current NDC, 2 package rows 20240418_109648d0-d30a-42fc-8273-39cb1540a751.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761334 Zynyz retifanlimab-dlwr 351(a) Rx 2026-07-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 50881-006-03 50881000603 1 VIAL, SINGLE-USE in 1 CARTON (50881-006-03) / 20 mL in 1 VIAL, SINGLE-USE 2023-03-22 No No Current